Your browser doesn't support javascript.
loading
A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis.
Stefanou, M I; Komorowski, L; Kade, S; Bornemann, A; Ziemann, U; Synofzik, M.
Afiliação
  • Stefanou MI; Department of Neurovascular Diseases, Hertie Institute for Clinical Brain Research & Center for Neurology, Tuebingen, Germany. maria-ioanna.stefanou@med.uni-tuebingen.de.
  • Komorowski L; Institute for Experimental Immunology, Affiliated to Euroimmun AG, Luebeck, Germany.
  • Kade S; Institute for Experimental Immunology, Affiliated to Euroimmun AG, Luebeck, Germany.
  • Bornemann A; Department of Neuropathology, University of Tuebingen, Tuebingen, Germany.
  • Ziemann U; Department of Neurovascular Diseases, Hertie Institute for Clinical Brain Research & Center for Neurology, Tuebingen, Germany.
  • Synofzik M; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center for Neurology, Tuebingen, Germany.
BMC Neurol ; 16(1): 172, 2016 Sep 13.
Article em En | MEDLINE | ID: mdl-27623618
ABSTRACT

BACKGROUND:

Myasthenia gravis is an autoimmune neuromuscular disorder, which has only rarely been reported to co-manifest with myositis. The diagnosis of concomitant myositis in patients with myasthenia gravis is clinically challenging, and requires targeted investigations for the differential diagnosis, including EMG, autoantibody assays, muscle biopsy and, importantly, imaging of the mediastinum for thymoma screening. CASE PRESENTATION This report presents a case-vignette of a 72-year-old woman with progressive proximal muscle weakness and myalgias, diagnosed with thymoma-associated myasthenia and bioptically verified granulomatous myositis, with positive autoantibody status for ryanodine receptor and titin antibodies.

CONCLUSIONS:

The diagnosis of concurrent myositis and myasthenia gravis, especially in the presence of ryanodine receptor and titin antibodies, should lead neurologists to adopt different treatment strategies compared to those applied in myasthenia or myositis alone. Moreover, further evidence is warranted that titin and, particularly, ryanodine receptor antibodies may co-occur or be pathophysiologically involved in myasthenia-myositis cases.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Timoma / Canal de Liberação de Cálcio do Receptor de Rianodina / Conectina / Miastenia Gravis / Miosite Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: BMC Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Timoma / Canal de Liberação de Cálcio do Receptor de Rianodina / Conectina / Miastenia Gravis / Miosite Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: BMC Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha
...